Alice Vuillermoz,Mathilde Lefranc,Nathan Prouvez,Clément Brault,Yoann Zerbib,Mary Schmitt,Jean-Marie Forel,Mathieu Le Tutour,Arnaud Lesimple,Alain Mercat,Jean-Christophe Richard,François M. Beloncle

Abstract:Nitric oxide (NO) is a strong vasodilator, selectively directed on pulmonary circulation through inhaled administration. In adult intensive care units (ICU), it is mainly used for refractory hypoxemia in mechanically ventilated patients. Several medical delivery devices have been developed to deliver inhaled nitric oxide (iNO). The main purpose of those devices is to guarantee an accurate inspiratory NO concentration, whatever the ventilator used, with NO 2 concentrations lower than 0.3 ppm. We hypothesized that the performances of the different available iNO delivery systems could depend on their working principle and could be influenced by the ventilator settings. The objective of this study was to assess the accuracy of seven different iNO-devices combined with different ICU ventilators' flow-by to reach inspiratory NO concentration targets and to evaluate their potential risk of toxicity.

Modes of administration of nitric oxide devices and ventilators flow-by impact the delivery of pre-determined concentrations